The Overall Response Rate Of Azacitidine In Patients With Intermidiate-2 And High Risk Myelodysplastic Syndromes- A Retrospective Chart Review Study From Greece
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.1307
https://www.valueinhealthjournal.com/article/S1098-3015(14)01358-8/fulltext
Section Title :
Systemic Disorders/Conditions
Section Order :
773
First Page :
A223
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01358-8&doi=10.1016/j.jval.2014.03.1307